{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:07:43Z","timestamp":1781658463441,"version":"3.54.5"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Canadian Institute of Health Research (CIHR)\/MHRC RPP grant","award":["#RPA-132176"],"award-info":[{"award-number":["#RPA-132176"]}]},{"name":"CIHR-IAVI Grant","award":["OVV-152411"],"award-info":[{"award-number":["OVV-152411"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0216949","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T13:25:14Z","timestamp":1558099514000},"page":"e0216949","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses"],"prefix":"10.1371","volume":"14","author":[{"given":"Zhujun","family":"Ao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelissa J.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keding","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Fowke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangguo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Kobinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5022-1309","authenticated-orcid":true,"given":"Xiaojian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"ref1","first-page":"123","article-title":"Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection","volume":"373","author":"DH Ho","year":"1995"},{"key":"ref2","first-page":"117","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection","volume":"373","author":"X Wei","year":"1995","journal-title":"Nat Med"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/cid\/cir728","article-title":"Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations","volume":"54","author":"V von Wyl","year":"2012","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11904-004-0003-1","article-title":"Current advances in HIV vaccines","volume":"1","author":"MP D\u2019Souza","year":"2004","journal-title":"Current HIV\/AIDS reports"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni1296","article-title":"HIV vaccine design: insights from live attenuated SIV vaccines","volume":"7","author":"WC Koff","year":"2006","journal-title":"Nature immunology"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"ofv082","DOI":"10.1093\/ofid\/ofv082","article-title":"First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)","volume":"2","author":"JD Fuchs","year":"2015","journal-title":"Open forum infectious diseases"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12977-016-0317-2","article-title":"First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses","volume":"13","author":"E Choi","year":"2016","journal-title":"Retrovirology"},{"issue":"14","key":"ref8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12981-017-0177-4","article-title":"Eradication of HIV-1 latent reservoirs through therapeutic vaccination","volume":"14","author":"J Pankrac","year":"2017","journal-title":"AIDS research and therapy"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1128\/JVI.75.5.2142-2153.2001","article-title":"Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals","volume":"75","author":"J Engelmayer","year":"2001","journal-title":"Journal of virology"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(01)00456-1","article-title":"Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity","volume":"106","author":"YJ Liu","year":"2001","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fimmu.2014.00255","article-title":"Dendritic cell-targeted vaccines","volume":"5","author":"L Cohn","year":"2014","journal-title":"Frontiers in immunology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/meth.1999.0839","article-title":"Dendritic cells as natural adjuvants","volume":"19","author":"S Citterio","year":"1999","journal-title":"Methods"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000000852","article-title":"Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial","volume":"71","author":"RT Gandhi","year":"2016","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/eji.201344433","article-title":"Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load","volume":"44","author":"Y L\u00e9vy","year":"2014","journal-title":"European Journal of Immunology"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/vim.2011.0044","article-title":"Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection","volume":"25","author":"J Pena","year":"2012","journal-title":"Viral Immunol"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/jiq077","article-title":"A therapeutic dendritic cell-based vaccine for HIV-1 infection","volume":"203","author":"F Garcia","year":"2011","journal-title":"The Journal of infectious diseases"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17121985","article-title":"Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis","volume":"17","author":"AV Coelho","year":"2016","journal-title":"International journal of molecular sciences"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.antiviral.2012.01.011","article-title":"The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge","volume":"93","author":"O Martinez","year":"2012","journal-title":"Antiviral research"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1128\/JVI.02695-12","article-title":"Ebola virus exploits a monocyte differentiation program to promote its entry","volume":"87","author":"O Martinez","year":"2013","journal-title":"Journal of virology"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.virol.2007.03.020","article-title":"Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain","volume":"364","author":"O Martinez","year":"2007","journal-title":"Virology"},{"issue":"6249","key":"ref22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"A Marzi","year":"2015","journal-title":"Science"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"A Huttner","year":"2015","journal-title":"The Lancet Infectious diseases"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(00)81248-9","article-title":"Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses","volume":"85","author":"WR Gallaher","year":"1996","journal-title":"Cell"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ymthe.2003.07.003","article-title":"Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung","volume":"8","author":"MF Medina","year":"2003","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2016.01.001","article-title":"Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection","volume":"127","author":"X Zhang","year":"2016","journal-title":"Antiviral research"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.01810-14","article-title":"Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity","volume":"89","author":"GS Mohan","year":"2015","journal-title":"Journal of virology"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/JVI.79.2.918-926.2005","article-title":"Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha","volume":"79","author":"A Yonezawa","year":"2005","journal-title":"Journal of virology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jviromet.2015.11.019","article-title":"Characterization of the single cycle replication of HIV-1 expressing Gaussia luciferase in human PBMCs, macrophages, and in CD4(+) T cell-grafted nude mouse","volume":"228","author":"Z Ao","year":"2016","journal-title":"Journal of virological methods"},{"issue":"18","key":"ref30","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1128\/JVI.00870-14","article-title":"Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography","volume":"88","author":"EE Tran","year":"2014","journal-title":"Journal of virology"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbrc.2005.05.171","article-title":"A cell line model for the differentiation of human dendritic cells","volume":"333","author":"C Berges","year":"2005","journal-title":"Biochemical and biophysical research communications"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2004.05.025","article-title":"Ebola and Marburg virus-like particles activate human myeloid dendritic cells","volume":"326","author":"CM Bosio","year":"2004","journal-title":"Virology"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1365-2567.2001.01164.x","article-title":"The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen-specific cytotoxic T-cell function","volume":"102","author":"JS Passmore","year":"2001","journal-title":"Immunology"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12985-016-0637-9","article-title":"Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412","volume":"13","author":"Z Ao","year":"2016","journal-title":"Virology journal"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1128\/IAI.71.8.4421-4431.2003","article-title":"Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone","volume":"71","author":"AJ Ritchie","year":"2003","journal-title":"Infection and immunity"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand","volume":"194","author":"P Pitisuttithum","year":"2006","journal-title":"The Journal of infectious diseases"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"NM Flynn","year":"2005","journal-title":"The Journal of infectious diseases"},{"issue":"23","key":"ref38","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2002-10-3189","article-title":"Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1","volume":"101","author":"H Donaghy","year":"2003","journal-title":"Blood"},{"issue":"19","key":"ref40","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood-2010-03-273763","article-title":"Evidence of dysregulation of dendritic cells in primary HIV infection","volume":"116","author":"RL Sabado","year":"2010","journal-title":"Blood"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.4049\/jimmunol.165.6.2982","article-title":"Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns","volume":"165","author":"BL Kelly","year":"2000","journal-title":"Journal of immunology"},{"issue":"5243","key":"ref42","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"F Cocchi","year":"1995","journal-title":"Science"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.00118-15","article-title":"Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers","volume":"89","author":"WE Walker","year":"2015","journal-title":"Journal of virology"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2010-12-327106","article-title":"Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers","volume":"118","author":"A Saez-Cirion","year":"2011","journal-title":"Blood"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/mt.sj.6300129","article-title":"Effects of MIP-1alpha, MIP-3alpha, and MIP-3beta on the Induction of HIV Gag-specific Immune Response with DNA Vaccines","volume":"15","author":"R Song","year":"2007","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"issue":"Suppl 2","key":"ref46","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1086\/520581","article-title":"Epitopes required for antibody-dependent enhancement of Ebola virus infection","volume":"196","author":"A Takada","year":"2007","journal-title":"The Journal of infectious diseases"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"e5547","DOI":"10.1371\/journal.pone.0005547","article-title":"Mucosal immunization of cynomolgus macaques with the VSVDeltaG\/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses","volume":"4","author":"X Qiu","year":"2009","journal-title":"PloS ONE"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0216949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:44:34Z","timestamp":1588967074000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0216949"}},"subtitle":[],"editor":[{"given":"Yuntao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0216949","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]}}}